Stock Events

Stock Events

Celldex Therapeutics (CLDX) Q3 2018 Earnings

8AugConfirmed

Q4 2017

Q1 2018

Q2 2018

Q3 2018

-4.15

-3.07

-1.98

-0.9

Details

Expected EPS

-1.66

Actual EPS

-1.65

Surprise EPS

0.01

Surprise Percent

+0.6%

Description

Celldex Therapeutics (CLDX) has reported earnings of -1.65 per share for Q3 2018.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.